Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT02203851 · COMPLETED
Trial details
- NCT number
- NCT02203851
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-20
- Primary completion
- 2018-09-04
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.